Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRB | O95718 | 9/20 | 0.54 |
| ▸ | ESRRG | P62508 | 17/20 | 0.50 |
| ▸ | ESR1 | P03372 | 5/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | ESRRA | P11474 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24688547 | 0.93 | ESRRG (0.49) | ESRRBESRRGESR1KCNH2 | |
| SCHEMBL29968359 | 0.88 | ESRRG (0.57) | ESRRBESRRGESR1KCNH2ESRRA | |
| SCHEMBL24688808 | 0.87 | ESRRG (0.50) | ESRRBESRRGESR1KCNH2 | |
| SCHEMBL24688923 | 0.83 | ESRRG (0.65) | ESRRBESRRGESR1KCNH2ESRRA | |
| SCHEMBL24688561 | 0.83 | ESRRG (0.51) | ESRRBESRRGESR1KCNH2 | |
| SCHEMBL24688558 | 0.82 | ESRRG (0.47) | ESRRBESRRGESR1KCNH2ESRRA | |
| SCHEMBL24688546 | 0.82 | ESRRG (0.67) | ESRRBESRRGESR1KCNH2 | |
| SCHEMBL24688812 | 0.81 | ESRRG (0.50) | ESRRBESRRGESR1KCNH2ESRRA | |
| SCHEMBL24688913 | 0.81 | ESRRG (0.57) | ESRRBESRRGESR1KCNH2ESRRA | |
| SCHEMBL24688811 | 0.81 | ESRRG (0.50) | ESRRBESRRGESR1KCNH2ESRRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022245124-A1 | NOVEL ETHENE COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 재단법인 대구경북첨단의료산업진흥재단 | 2022-11-24 | — | — | WO | disclosed |